期刊文献+

术前生化指标与分化型甲状腺癌术后首次131I内照射疗效的关系

Relationship between preoperative biochemical indexes and effect of postoperative first 131I internal irradiation for differentiated thyroid carcinoma
原文传递
导出
摘要 目的 分析131I内照射术前各项生化指标与分化型甲状腺癌术后首次131I内照射疗效的关系.方法 对180例分化型甲状腺癌术后首次131I内照射治疗的患者按内照射疗效分为有效组(96例)和无效组(84例),对其临床资料进行回顾性分析.结果 有效组和无效组患者内照射术前血清碱性磷酸酶(AKP)和促甲状腺激素(TSH)分别为(74.83±19.77)、(65.50±11.84)U/L和(3.12±0.59)、(2.57±0.56)mU/L,差异有统计学意义(t=3.77、6.39,P〈0.01).结论 术前血清AKP和TSH水平是影响分化型甲状腺癌术后首次131I内照射疗效的重要因素. Objective To analyze the relationship between preoperative biochemical indexes and effect ofpostoperative first 131I internal irradiation for differentiated thyroid carcinoma. Methods One hundred and eighty patients of thyroid carcinoma within the first 131I internal irradiation postoperative. According to curative effect were divided into effective group (96 cases) and invalid group (84 cases) and their clinical data were retrospectively analyzed. Results The preoperative serum alkaline phosphatase (AKP) and thyroid-stimulating hormone (TSH) in effective group and invalid group were respectively (74.83 ± 19.77),(65.50 ± 11.84) U/L and (3.12 ±0.59), (2.57 ±0.56) mU/L. There were significant difference (t =3.77,6.39, P 〈 0.01) between two groups. Conclusion The levels of preoperative serum A KP and TSH are important factors to influence the effect of postoperative first 131I internal irradiation for differentiated thyroid carcinoma.
作者 胡锟 孙圣荣
出处 《中国医师进修杂志》 2011年第2期19-21,共3页 Chinese Journal of Postgraduates of Medicine
关键词 甲状腺肿瘤 碘苷 碱性磷酸酶 促甲状腺素 Thyroid neoplasms Idoxuridine Alkaline phosphatase Thyrotropin
  • 相关文献

参考文献9

二级参考文献44

  • 1张一帆,李彪,赵龙,朱承谟.维甲酸诱导甲状腺癌细胞摄碘的实验研究[J].中华核医学杂志,2005,25(2):90-93. 被引量:5
  • 2管昌田,于南,潘明志,匡安仁,谭天秩.分化好的甲状腺癌转移灶的^(131)I治疗[J].中华核医学杂志,1995,15(1):32-34. 被引量:22
  • 3张雯杰,郑容,林琳,李家琇,贾莹莹,刘琳,陈盛祖.维甲酸诱导分化在分化型甲状腺癌治疗中的初步应用[J].实用癌症杂志,2005,20(4):396-398. 被引量:3
  • 4张一帆,贾士铨,李彪,刘勇,王朝晖,朱承谟.维甲酸诱导分化治疗甲状腺癌的临床研究[J].中华内分泌代谢杂志,2006,22(2):101-104. 被引量:5
  • 5Menzel C, Granwald F,Schomburg A, et al. High dose radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med,1996,37:1496-1503.
  • 6Grunwald F, Ruhlmann J, Ammari B,et al. Experience with a high dose therapy concept in metastatic differentiated thyroid cancer.Nuklearmedizin,1988,27:266-271.
  • 7Maier H,Bihl H. Effect of radioactive iodine therapy on parathyroid function. Acta-otolaryngol, 1987,10:318-324.
  • 8Aldrich LB.Pulmonary function on thyroid carcinoma metastatic to the lung.J Endocrinol Invest,1987,10:111-116.
  • 9M'Kacher R.Sequential biological dosimetry after a single treatment with 131I for differentiated thyroid carcinoma. J Nucl Med,1997,38:377-380.
  • 10Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma effect of therapy. Endocr Pract, 2000,6:469-476.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部